RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vistin Pharma A Stock

Vistin Pharma A Revenue 2024

Vistin Pharma A Revenue

435.39 M NOK

Ticker

VISTN.OL

ISIN

NO0010734122

WKN

A14TLR

In 2024, Vistin Pharma A's sales reached 435.39 M NOK, a 51.35% difference from the 287.68 M NOK sales recorded in the previous year.

The Vistin Pharma A Revenue history

YEARREVENUE (undefined NOK)GROSS MARGIN (%)
2023435.3959,43
2022287.6852,01
2021275.8165,16
2020253.1671,05
2019227.1945,64
2018198.9941,52
2017176.6941,36
2016170.5163,46
2015218.3762,61

Vistin Pharma A Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Vistin Pharma A, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Vistin Pharma A from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Vistin Pharma A’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Vistin Pharma A. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Vistin Pharma A’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Vistin Pharma A’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Vistin Pharma A’s growth potential.

Vistin Pharma A Revenue, EBIT and net profit per share

DateVistin Pharma A RevenueVistin Pharma A EBITVistin Pharma A Net Income
2023435.39 M undefined68.6 M undefined45.6 M undefined
2022287.68 M undefined-6.1 M undefined-4.72 M undefined
2021275.81 M undefined33.25 M undefined24.87 M undefined
2020253.16 M undefined45.56 M undefined-96.96 M undefined
2019227.19 M undefined16.77 M undefined66.2 M undefined
2018198.99 M undefined-4.61 M undefined-73.63 M undefined
2017176.69 M undefined14.02 M undefined70.4 M undefined
2016170.51 M undefined21.93 M undefined12.92 M undefined
2015218.37 M undefined26.32 M undefined19.12 M undefined

Vistin Pharma A stock margins

The Vistin Pharma A margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Vistin Pharma A. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Vistin Pharma A.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Vistin Pharma A's sales revenue. A higher gross margin percentage indicates that the Vistin Pharma A retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Vistin Pharma A's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Vistin Pharma A's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Vistin Pharma A's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Vistin Pharma A. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Vistin Pharma A's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Vistin Pharma A Margin History

Vistin Pharma A Gross marginVistin Pharma A Profit marginVistin Pharma A EBIT marginVistin Pharma A Profit margin
202359.43 %15.76 %10.47 %
202252.01 %-2.12 %-1.64 %
202165.16 %12.06 %9.02 %
202071.05 %17.99 %-38.3 %
201945.64 %7.38 %29.14 %
201841.52 %-2.31 %-37 %
201741.36 %7.93 %39.84 %
201663.46 %12.86 %7.58 %
201562.61 %12.05 %8.76 %

Vistin Pharma A Aktienanalyse

What does Vistin Pharma A do?

Vistin Pharma ASA is a Norwegian company specializing in the production and sale of chemical products. The company was founded in 1997 and is headquartered in Oslo. History: The company started as a chemical products manufacturer but quickly began focusing on the production of pharmaceutical products and active ingredients in the early 2000s. In 2016, the subsidiary Vistin Pharma Production AS was established, specializing in the production of active ingredients for the chemical industry. Business model: Vistin Pharma is a niche provider of specialized chemical and pharmaceutical products. The company focuses on producing high-quality products for selected markets and industries where it has a competitive position. The business model is based on a combination of advanced research and development, state-of-the-art production facilities, and a comprehensive network of sales partners and distributors. Different divisions: Vistin Pharma's business activities mainly focus on two main divisions: Pharmaceuticals and Industrial Active Ingredients. The Pharmaceuticals division includes the production and sale of active ingredients for the production of human and animal health medications. The products include Metformin, an active ingredient for treating diabetes, as well as Methotrexate tablets for cancer treatment. The Industrial Active Ingredients division produces active ingredients for various industries, including cosmetics, food, and energy sectors. Products: One of Vistin Pharma's best-known products is Metformin, an orally administered medication for treating type 2 diabetes. Metformin helps control and lower blood sugar levels by preventing the liver from producing too much glucose and improving the body's sensitivity to insulin. Vistin Pharma's Methotrexate tablets are used to treat a variety of cancers, including breast cancer, lung cancer, and leukemia. Overall, Vistin Pharma offers a wide range of chemical and pharmaceutical products suitable for various applications. The company places great emphasis on quality and sustainability and strives to offer its customers high-quality and environmentally friendly products and services. Conclusion: Vistin Pharma is an innovative Norwegian pharmaceutical and chemical company that has been focused on producing and selling high-quality products since its inception. With a wide range of chemical and pharmaceutical products and a strong focus on research and development, product quality, and sustainability, Vistin Pharma is well-positioned to continue growing and establish itself as a leading provider in its core markets. The output translation is: Vistin Pharma ASA is a Norwegian company specializing in the production and sale of chemical and pharmaceutical products. It was founded in 1997 and is headquartered in Oslo. The company has expanded from being a chemical products manufacturer to producing pharmaceutical products and active ingredients. It operates through two main divisions: Pharmaceuticals and Industrial Active Ingredients. Vistin Pharma's products include Metformin for treating diabetes and Methotrexate tablets for cancer treatment. The company focuses on providing high-quality and environmentally friendly products and services. With its strong emphasis on research and development, product quality, and sustainability, Vistin Pharma aims to become a leading player in its core markets. Vistin Pharma A ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Vistin Pharma A's Sales Figures

The sales figures of Vistin Pharma A originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Vistin Pharma A’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Vistin Pharma A's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Vistin Pharma A’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Vistin Pharma A stock

How much revenue did Vistin Pharma A generate this year?

Vistin Pharma A has achieved a revenue of 435.39 M NOK this year.

How much was the turnover of the company Vistin Pharma A compared to the previous year?

The revenue of Vistin Pharma A has increased by 51.35% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Vistin Pharma A?

The revenue of Vistin Pharma A is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Vistin Pharma A measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Vistin Pharma A so important for investors?

The revenue of Vistin Pharma A is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Vistin Pharma A pay?

Over the past 12 months, Vistin Pharma A paid a dividend of 0.75 NOK . This corresponds to a dividend yield of about 2.87 %. For the coming 12 months, Vistin Pharma A is expected to pay a dividend of 0.75 NOK.

What is the dividend yield of Vistin Pharma A?

The current dividend yield of Vistin Pharma A is 2.87 %.

When does Vistin Pharma A pay dividends?

Vistin Pharma A pays a quarterly dividend. This is distributed in the months of June, February, July, December.

How secure is the dividend of Vistin Pharma A?

Vistin Pharma A paid dividends every year for the past 0 years.

What is the dividend of Vistin Pharma A?

For the upcoming 12 months, dividends amounting to 0.75 NOK are expected. This corresponds to a dividend yield of 2.87 %.

In which sector is Vistin Pharma A located?

Vistin Pharma A is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vistin Pharma A kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vistin Pharma A from 11/19/2024 amounting to 0.5 NOK, you needed to have the stock in your portfolio before the ex-date on 11/6/2024.

When did Vistin Pharma A pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Vistin Pharma A in the year 2023?

In the year 2023, Vistin Pharma A distributed 0.5 NOK as dividends.

In which currency does Vistin Pharma A pay out the dividend?

The dividends of Vistin Pharma A are distributed in NOK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Vistin Pharma A

Our stock analysis for Vistin Pharma A Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vistin Pharma A Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.